X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank100
3Y CAGR+30.5%
5Y CAGR+27.0%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+30.5%/yr
vs +40.0%/yr prior
5Y CAGR
+27.0%/yr
Recent acceleration
Acceleration
-9.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
7 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.88M | +1.2% |
| 2024 | $8.77M | +51.8% |
| 2023 | $5.78M | +44.7% |
| 2022 | $3.99M | +9.6% |
| 2021 | $3.64M | +35.5% |
| 2020 | $2.69M | +25.2% |
| 2019 | $2.15M | +106.6% |
| 2018 | $1.04M | -50.0% |
| 2017 | $2.08M | -17.3% |
| 2016 | $2.52M | - |